| TRI
Sections |
 |
SECTION
ON BEHAVIORAL INTERVENTIONS
Director: Kimberly C. Kirby, Ph.D.
Selected
Projects: Research and Evaluation
Survey
of Counselors’ Attitudes Toward Incentive Programs; Kimberly Kirby,
Ph.D.
Contingency management (CM) programs that provide incentives to patients
for demonstrated drug abstinence are not widely used in community treatment
programs despite abundant empirical evidence that use of incentives is
associated with better treatment outcomes. The Provider Survey of Incentives
(PSI), a 44-item survey, was developed, validated, and administered to
383 treatment providers to assess positive and negative beliefs regarding
tangible and social incentives. Positive beliefs were more prevalent among
respondents (67%) with 54% favorably inclined to adding a tangible CM
program to their treatment programs. The most prevalent objections to
incentive programs were cost, failure to address underlying problems of
addiction, and failure to address multiple behaviors. Social incentives
were viewed more favorably than tangible incentives and both were viewed
more positively by providers who were supervisors, had advanced degrees,
had more addictions experience, and had previous experience with tangible
incentives. This research supported by the National Institute on Drug
Abuse and the Pennsylvania Department of Health has implications for improving
the dissemination of CM, an empirically-demonstrated treatment strategy.
View article
Family
Training for Concerned Significant Others of Drug and Alcohol Users; Kimberly
Kirby, Ph.D. In this NIDA-funded study, family members and
significant others seeking help regarding an adult
loved one using drugs or drinking too much were randomly assigned to one
of the three family training models. Family training counselors provided
guidance and personalized referrals. The results are being evaluated for
change in rates of treatment seeking and retention, and family member
life improvement and intervention satisfaction. A similar project is planned
focused on assisting parents and guardians concerned about their adolescent
with a drug or alcohol problem – particularly adolescents who are
resistant to treatment, either refusing to show or dropping out before
making gains.
Treatment
Administrators’ Views of Empirically-Supported Drug AbuseTreatments;
Lois Benishek, Ph.D.
Financial concerns and limited resources for staff training are barriers
to introduction of empirically supported drug abuse treatments (ESTs),
according to this survey of clinical administrators conducted with funding
from the Pennsylvania Department of Health and the National Institute
on Drug Abuse. The survey was designed to 1) assess administrators’
knowledge of and attitudes toward ESTs versus treatments with little empirical
support (ie, 12-step programs), 2) assess change in attitudes and willingness
to implement ESTs after introduction of educational material, 3) investigate
the extent to which administrators’ characteristics are associated
with changes in their attitudes and willingness to implement ESTs, and
(d) understand perceived barriers to and methods for integrating ESTs
into existing outpatient treatment programs.. Administrator subjects were
surveyed prior to and after reading information about five treatments
with varying levels of empirical support: contingency management (CM);
relapse prevention, motivational interviewing, 12-step, and verbal confrontation.
Preliminary results suggest that 1) information is associated with changes
in beliefs about some interventions (CM) but not others (12-step), 2)
demographic characteristics can be predictors in changes in administrators’
beliefs, and 3) financial concerns and limited resources for staff training
are frequently reported barriers to implementing ESTs.
Motivational
Incentives to Enhance Drug Abuse Recovery; Kimberly Kirby, Ph.D.
Research shows that tangible rewards for drug-free urine samples reliably
increase treatment retention and drug abstinence, but that applying incentives
in practice is often prohibitively expensive for clinics. This study,
part of a multisite trial under NIDA’s Clinical Trials Network,
tested a less expensive reward system with cocaine-using patients in drug-free
and methadone maintenance clinics. Through lottery drawing patients were
given a 1:2 chance to earn low-cost items each time they submitted a cocaine-free
urine, with substantially lower chance of earning a larger or a grand
prize. In the drug-free outpatient settings, the incentive procedure cost
an average of $68/month/participant and was efficacious in improving retention
and abstinence outcomes. In the methadone clinics, at an average cost
of $40/month/participant, similar improvements in abstinence rates were
noted. Attendance rates were unchanged in the methadone group where rates
of treatment attendance are typically high. View
Publications.
More
Projects >>
|